secwatch.observer — SEC 8-K summary
======================================

Issuer:     Advanced Biomed Inc. (ADVB)
CIK:        0001941029
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001575872-25-000240
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Advanced Biomed closes $6.56M IPO of 1.64M shares at $4.00; Nasdaq ADVB
-----------------------------------------------------------------------

- Priced 1,640,000 shares at $4.00/share for gross proceeds of $6.56 million.
- Underwriter granted 45-day option to purchase up to 246,000 additional shares.
- Representative's warrants to purchase 98,400 shares at $5.00/share.
- Proceeds to fund IVD clinical research, chip development, marketing, and working capital.
- Shares commenced trading on Nasdaq Capital Market on March 6, 2025 under ticker ADVB.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1941029/000157587225000240/0001575872-25-000240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1941029/000157587225000240/advb-20250307.htm
  HTML page:      https://secwatch.observer/filing/0001575872-25-000240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer